Eli Lilly cuts insulin prices by 70%

CNBC's Meg Tirrell joins 'The Exchange' to discuss Eli Lilly's decision to set insulin price caps, the motivations behind the company's decision, and whether or not other insulin producers will join them in cutting prices.